The Quantellect read.As of Nov 20, 2026, 20 active firms cover UnitedHealth Group Incorporated: 17 rate it Buy or better, 3 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $330.00 to $529.00, a moderate spread. The average target of $459.60 sits 39% above the current $330.65. The rating mix has stayed broadly stable, with Buy-side ratings easing from 18 to 17 over recent months. On the fundamentals, the Street sees consensus EPS building from about $8.17 next quarter toward $23.33 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 active firms
Buy
Strong Buy00%
Buy1785%
Neutral315%
Sell00%
Strong Sell00%
Based on 20 active firms as of Nov 20, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$459.60
+39.0% upside
Average target across 20 active firms as of Nov 20, 2026 vs $330.66 current
Highest Target$529.00
Average Target$459.60
Lowest Target$330.00
Detailed analyst forecasts for UNH
Showing 1–21 of 21 named analysts shown · 20 active firms in the rating projection
As of Nov 20, 2026, 17 of 20 active firms rate UNH a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
UNH EPS & revenue forecast
EPS · NEXT QUARTER
$8.17
Range $6.53 – $9.06 · 16 analysts · +13% YoY
Next period, 16 analysts expect UnitedHealth Group Incorporated to earn $8.17 a share (range $6.53 – $9.06), versus $7.23 a year earlier. Full-year consensus is $20.52, growing to $23.33 the year after.
REVENUE · NEXT QUARTER
$113.7B
Range $109.7B – $117.6B · 16 analysts · +2% YoY
Revenue is expected to reach $113.7B (range $109.7B – $117.6B), +1.8% year-over-year. Full-year consensus is $449.0B, rising to $462.9B next year.
Top analysts covering UnitedHealth Group Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on UNH.
#1
Stephen Baxter
Wells Fargo · Rank #63
Buy
$526.00+59.1% to target
Overall win rate
47%
+ Follow
#2
Erin Wright
Morgan Stanley · Rank #81
Buy
$529.00+60.0% to target
Overall win rate
55%
+ Follow
#3
DM
David Macdonald
Truist Securities · Rank #111
Buy
$500.00+51.2% to target
Overall win rate
50%
+ Follow
#4
Ben Hendrix
RBC Capital · Rank #150
Buy
$478.00+44.6% to target
Overall win rate
44%
+ Follow
#5
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$440.00+33.1% to target
Overall win rate
37%
+ Follow
UNH stock forecast FAQ
What is UNH's average 12-month price target?+
The 20 active firms with a live target average $459.60 for UnitedHealth Group Incorporated over the next 12 months, ranging from a $529.00 high to a $330.00 low, as of Nov 20, 2026.
Is UNH stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 20 active firms as of Nov 20, 2026, 17 rate it Buy or Strong Buy, 3 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for UNH?+
The Street-high target is $529.00 (Morgan Stanley), and the Street-low is $330.00 (Raymond James). The average of all 20 active-firm targets is $459.60.
How many active Wall Street firms cover UNH?+
20 active firms have a recognized rating on UnitedHealth Group Incorporated as of Nov 20, 2026, and 20 active firms carry a live 12-month price target.
Who is the most accurate analyst covering UNH?+
Among analysts who currently cover UNH, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Buy with a $526.00 target.
What is UnitedHealth Group Incorporated's projected EPS for next quarter?+
The consensus estimate is $8.17 per share (range $6.53 – $9.06) across 16 analysts. Full-year EPS is projected at $20.52, rising to $23.33 the following year.
How much revenue is UnitedHealth Group Incorporated expected to report next quarter?+
Consensus revenue is $113.7B (range $109.7B – $117.6B). Full-year revenue is projected at $449.0B, growing to $462.9B next year.
Have analysts been upgrading or downgrading UNH lately?+
As of Nov 20, 2026, 17 of 20 active firms rate UNH a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their UNH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.